Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy
Rebecca J. Brown, Elif A Oral, Elaine Cochran, et al.
Endocrine (2018) Vol. 60, Iss. 3, pp. 479-489
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents
Andrew T. Hattersley, Siri Atma W. Greeley, Michel Polak, et al.
Pediatric Diabetes (2018) Vol. 19, pp. 47-63
Open Access | Times Cited: 281
Leptin as a key regulator of the adipose organ
Catalina Picó, Mariona Palou, Catalina Amadora Pomar, et al.
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 23, Iss. 1, pp. 13-30
Open Access | Times Cited: 151
Leptin in Leanness and Obesity
Nikolaos Perakakis, Olivia M. Farr, Christos S. Mantzoros
Journal of the American College of Cardiology (2021) Vol. 77, Iss. 6, pp. 745-760
Open Access | Times Cited: 110
ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents
Siri Atma W. Greeley, Michel Polak, Pål R. Njølstad, et al.
Pediatric Diabetes (2022) Vol. 23, Iss. 8, pp. 1188-1211
Open Access | Times Cited: 110
Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement
Stergios A. Pοlyzos, Nikolaos Perakakis, Christos S. Mantzoros
Metabolism (2019) Vol. 96, pp. 66-82
Closed Access | Times Cited: 90
Short-term metreleptin treatment of patients with anorexia nervosa: rapid on-set of beneficial cognitive, emotional, and behavioral effects
Gabriella Milos, Jochen Antel, Lisa‐Katrin Kaufmann, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 90
The pleiotropic roles of leptin in metabolism, immunity, and cancer
Paola de Candia, Francesco Prattichizzo, S. Garavelli, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 5
Open Access | Times Cited: 84
Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy
Elif A Oral, Phillip Görden, Elaine Cochran, et al.
Endocrine (2019) Vol. 64, Iss. 3, pp. 500-511
Open Access | Times Cited: 80
Leptin hormone and its effectiveness in reproduction, metabolism, immunity, diabetes, hopes and ambitions
Hany Akeel Al-Hussaniy, Ali Hikmat Alburghaif, Meena Akeel Naji
Journal of Medicine and Life (2021) Vol. 14, Iss. 5, pp. 600-605
Open Access | Times Cited: 76
Investigating the Physiologic Role of Leptin and Its Relationship to Obesity
Mahmoud Kallash, William H. Frishman
Cardiology in Review (2025)
Closed Access | Times Cited: 1
<p>Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy</p>
Oluwayemisi Esan, Anthony S. Wierzbicki
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 2623-2636
Open Access | Times Cited: 68
Leptin alters energy intake and fat mass but not energy expenditure in lean subjects
Pavlina Chrysafi, Nikolaos Perakakis, Olivia M. Farr, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 66
Lipodystrophy: A paradigm for understanding the consequences of "overloading" adipose tissue
Koini Lim, Afreen Haider, Claire Adams, et al.
Physiological Reviews (2020)
Closed Access | Times Cited: 62
Clinical Trials Required to Assess Potential Benefits and Side Effects of Treatment of Patients With Anorexia Nervosa With Recombinant Human Leptin
Johannes Hebebrand, Gabriella Milos, Martin Wabitsch, et al.
Frontiers in Psychology (2019) Vol. 10
Open Access | Times Cited: 59
<p>Familial Partial Lipodystrophy (FPLD): Recent Insights</p>
Christos Bagias, Angeliki Xiarchou, Αlexandra Bargiota, et al.
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 1531-1544
Open Access | Times Cited: 58
Rapid amelioration of anorexia nervosa in a male adolescent during metreleptin treatment including recovery from hypogonadotropic hypogonadism
Jochen Antel, Susanne Tan, Marvin Grabler, et al.
European Child & Adolescent Psychiatry (2021) Vol. 31, Iss. 10, pp. 1573-1579
Open Access | Times Cited: 42
Detangling the interrelations between MAFLD, insulin resistance, and key hormones
Shreya C. Pal, Mohammed Eslam, Nahúm Méndez‐Sánchez
HORMONES (2022) Vol. 21, Iss. 4, pp. 573-589
Closed Access | Times Cited: 30
Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery
Michail Kokkorakis, Angeliki Katsarou, Niki Katsiki, et al.
Metabolism (2023) Vol. 148, pp. 155689-155689
Open Access | Times Cited: 21
Clinical Spectrum of LMNA-Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review
Antía Fernández‐Pombo, Everardo Josué Díaz‐López, Ana I. Castro, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 725-725
Open Access | Times Cited: 18
Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy
Maria Cristina Foss‐Freitas, Salman Imam, Adam Neidert, et al.
Diabetes Care (2024) Vol. 47, Iss. 4, pp. 653-659
Open Access | Times Cited: 7
GLP-1 receptor agonist improves metabolic disease in a pre-clinical model of lipodystrophy
Ahlima Roumane, George D. Mcilroy, Nadine Sommer, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6
Comorbidities and Survival in Patients With Lipodystrophy: An International Chart Review Study
Barış Akıncı, Elif A Oral, Adam Neidert, et al.
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 104, Iss. 11, pp. 5120-5135
Open Access | Times Cited: 53
Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real‐life experience from a national reference network
Héléna Mosbah, Marie‐Christine Vantyghem, Estelle Nobécourt, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 8, pp. 1565-1577
Open Access | Times Cited: 24
Advances in Phenotyping Obesity and in Its Dietary and Pharmacological Treatment: A Narrative Review
Roberta Pujia, Maria Grazia Tarsitano, Franco Arturi, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 23
A rapid action plan to improve diagnosis and management of lipodystrophy syndromes
Lindsay T. Fourman, Josivan Gomes Lima, Vinaya Simha, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top